Experimental validation and pan-cancer analysis identified COL10A1 as a novel oncogene and potential therapeutic target in prostate cancer
Figure 6.Relationship between COL10A1 expression and clinical character. Correlation between tumor stage and COL10A1 (A). Correlation between gender and COL10A1 (B). Correlation between age and COL10A1 (C). *p < 0.05, **p < 0.01 and ***p < 0.001.